Showing 2041 results
-
Event /Novartis announces the company’s fourth quarter and 2019 full year financial results.
-
Event /Novartis CEO Vas Narasimhan announced the company’s fourth quarter and 2018 full year results.
-
Event /Novartis announces the company’s fourth quarter and 2025 full year financial results.
-
Media Library / -
Media Library / -
Media Library / -
Clinical Trials /
-
Story /Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.
-
Story /Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world.